Company News, Financial News

Kenvue Reports Q2 Performance

“Our second quarter results mark a strong debut for Kenvue, reflecting the strength of our portfolio of iconic brands,” said CEO Thibaut Mongon.

Author Image

By: Christine Esposito

Editor-in-Chief

Happi 2023 Top 50 company, Kenvue Inc.— home to Neutrogena, Listerine, Aveeno and Tylenol—has reported its results for the fiscal second quarter ended July 2, 2023. This is the first release of its financial performance since becoming a standalone operation. On a reported basis, net sales in the second quarter of 2023 were $4.0 billion, a 5.4% increase versus the prior year period. Foreign currency fluctuations negatively impacted net sales by approximately 2.3%. Organic growth increased 7.7%...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters